688197 Shouyao Holdings
- 36.06
- +1.35+3.89%
Shouyao Holdings News
Announcement of First Pharmaceutical Holdings (Beijing) Co., Ltd. on participating in the 2024 semi-annual special group performance briefing on pharmaceuticals and biological products
First Pharmaceutical Holdings (Beijing) Co., Ltd. Investor Relations Activity Record Form (August 30, 2024)
Shouyao Holdings: CSC Securities Co., Ltd.'s Continuous Supervision and Tracking Report on Shouyao Holdings (Peking) Co., Ltd. for the First Half of 2024
Shouyao Holdings: Announcement on the Resolutions of the Fourth Meeting of the Second Supervisory Board of Shiyao Holdings (Peking) Co., Ltd.
Shouyao Holdings: Announcement of Shuyao Holdings (Peking) Co., Ltd. on the resolutions of the fifth meeting of the second session of the Board of Directors
Shouyao Holdings: Shuoyao Holdings (Beijing) Co., Ltd. voluntarily disclosed the announcement of SY-7166 obtaining the notice of drug clinical trial approval.
Shouyao Holdings: Special Report on the Deposit and Actual Use of Funds Raised by Beijing Pharmaceutical Holdings Co., Ltd. for the First Half of 2024.
Shouyao Holdings: The semi-annual evaluation report on the "Improve Efficiency and Return" action plan of Shouyao Holdings (Beijing) Co., Ltd. for the year 2024.
Shouyao Holdings: CSC's verification opinion on the increase of idle funds' investment quota and investment scope of Shouyao Holdings (Beijing) Co., Ltd.
Announcement Regarding the Reappointment of Accounting Firm by Peking Pharmaceuticals Holdings Co., Ltd.
CSC's verification opinion on the increase of idle funds' investment quota and investment scope of Shouyao Holdings (Beijing) Co., Ltd.
Special Report on the Deposit and Actual Use of Funds Raised by Beijing Pharmaceutical Holdings Co., Ltd. for the First Half of 2024.
Announcement on the Resolutions of the Fourth Meeting of the Second Supervisory Board of Shiyao Holdings (Peking) Co., Ltd.
Announcement of Shuyao Holdings (Peking) Co., Ltd. on the resolutions of the fifth meeting of the second session of the Board of Directors
The semi-annual evaluation report on the "Improve Efficiency and Return" action plan of Shouyao Holdings (Beijing) Co., Ltd. for the year 2024.
CSC Securities Co., Ltd.'s Continuous Supervision and Tracking Report on Shouyao Holdings (Peking) Co., Ltd. for the First Half of 2024
Shuoyao Holdings (Beijing) Co., Ltd. voluntarily disclosed the announcement of SY-7166 obtaining the notice of drug clinical trial approval.
Investor Relations Activity Record Form (June 19, 2024) of Shuyao Holdings (Peking) Co., Ltd.
Announcement by Peking Prime Medicine Holdings Co., Ltd. on the convening of the 2023 annual and Q1 2024 performance briefing.
CITIC Construction Investment Securities Co., Ltd. inspection report on shareholders of Shouyao Holdings (Beijing) Co., Ltd. requesting quotations to transfer shares to specific institutional investors
Analysis
Price Target
No Data
